<!DOCTYPE html>
<html>

<head>
	<meta charset="UTF-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title>Septic Arthritis</title>
	<link href="/index.css" type="text/css" rel="stylesheet">
	<script src="//code.jquery.com/jquery-1.10.2.js"></script>
	<script>
		$(function () {
			$("header").load("/header.html");
			$("footer").load("/footer.html");
		});
	</script>
	<script>
		function navDrop() {
			var x = document.getElementById('navlinks');
			if (x.style.display === 'flex') {
				x.style.display = 'none';
			} else {
				x.style.display = 'flex';
			}
		}
	</script>
</head>

<body>
	<header></header>
	<div class="spacer"></div>
	<div class="main">
		<h2 id="septic-arthritis">Septic Arthritis</h2>
		<h3 id="epidemiology-3">Epidemiology</h3>
		<p>Native joint septic arthritis has an annual incidence of 2-12 per 100,000 people per year.</p>
		<p>Risk factors include:</p>
		<ul>
			<li>
				<p>Advanced age (&gt;65 years old)</p>
			</li>
			<li>
				<p>Concomitant rheumatoid arthritis (28-70 per 100,000 people per year)</p>
			</li>
			<li>
				<p>Anti-TNF<span class="math inline"><em>α</em></span> therapy</p>
			</li>
			<li>
				<p>Lower socio-economic status.</p>
			</li>
		</ul>
		<hr />
		<div class="table">
			<table>
				<caption><strong>Table 1.</strong> Factors affecting septic arthritis.</caption>
				<thead>
					<tr class="header">
						<th>Major Factors</th>
						<th>Minor Factors</th>
					</tr>
				</thead>
				<tbody>
					<tr class="odd">
						<td>
							<p>Rheumatoid arthritis</p>
							<p>Crystal arthropathy</p>
							<p>Advanced age</p>
							<p>Diabetes mellitus</p>
							<p>Chronic renal failure</p>
							<p>Previous joint surgery</p>
							<p>Penetrating joint injury</p>
							<p>Intravenous drug use</p>
							<p>Endocarditis</p>
							<p>Immunosuppression</p>
							<p>Organ and bone marrow transplant</p>
							<p>Immunosuppressant therapy</p>
						</td>
						<td>
							<p>Other joint disease</p>
							<p>Osteoarthritis</p>
							<p>Charcot arthropathy</p>
							<p>Chronic systemic disease</p>
							<p>Collagen vascular disease</p>
							<p>Malignancy</p>
							<p>Chronic liver disease</p>
							<p>Sickle cell disease</p>
							<p>Alcoholism</p>
							<p>Hypogammaglobulinemia</p>
							<p>Intra-articular injection (e.g., glucocorticoids)</p>
							<p>Skin disease with or without infection</p>
							<p>Low socioeconomic status</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<h3 id="pathophysiology-2">Pathophysiology</h3>
		<p>Synovium is susceptible to hematogenous seeding because it is vascularized but lacks a basement membrane.</p>
		<p>Gram-positive organisms bind connective tissue and extracellular matrix proteins better than Gram-negative
			organisms.</p>
		<p>Cartilage, which is avascular and dependent on the synovium for oxygen and nutrients, is damaged by:</p>
		<ul>
			<li>
				<p>Bacterial enzymes and toxins</p>
			</li>
			<li>
				<p>White blood cell lysosomal proteases and reactive oxygen species</p>
			</li>
		</ul>
		<p>Routes of infection include:</p>
		<ul>
			<li>
				<p>Adjacent skin and soft tissue injury (skin flora)</p>
			</li>
			<li>
				<p>Urosepsis (urogenital flora)</p>
			</li>
			<li>
				<p>Bacterial translocation (gastrointestinal flora)</p>
			</li>
			<li>
				<p>IV drug use</p>
			</li>
			<li>
				<p>Direct innoculation secondary to:</p>
			</li>
			<ul>
				<li>
					<p>Surgery</p>
				</li>
				<li>
					<p>Penetrating trauma</p>
				</li>
				<li>
					<p>Human or animal bites</p>
				</li>
			</ul>
		</ul>
		<h3 id="etiology-5">Etiology</h3>
		<p><em>S. aureus</em> is the most common bacterial pathogen (42% MSSA and 10% MRSA), followed by:</p>
		<ul>
			<li>
				<p>Coagulase-negative <em>Staphylococcus</em> spp.</p>
			</li>
			<li>
				<p><em>Streptococci</em> spp.</p>
			</li>
			<li>
				<p>Gram-negative bacilli</p>
			</li>
			<li>
				<p><em>M. tuberculosis</em></p>
			</li>
			<li>
				<p><em>N. gonorrhoeae</em></p>
			</li>
			<li>
				<p>Anaerobes</p>
			</li>
			<li>
				<p><em>Borrelia burgdorferi</em></p>
			</li>
		</ul>
		<p>Among the coagulase-negative <em>Staphylococcus</em> spp, <em>S. lugdunensis</em> is especially
			virulent.</p>
		<p>GB<em>S</em> often causes infection in neonates and the elderly, especially those with:</p>
		<ul>
			<li>
				<p>Diabetes</p>
			</li>
			<li>
				<p>Cirrhosis</p>
			</li>
			<li>
				<p>Malignancy</p>
			</li>
			<li>
				<p>Genitourinary structural abnormalities</p>
			</li>
			<li>
				<p>Neurologic disease</p>
			</li>
		</ul>
		<p>Pneumococcus formerly compromised 6% of cases but more recently was found to account for only 3% of cases,
			most likely due to more widespread immunization.</p>
		<p>Gonococcus now accounts for 1–3% of cases but is becoming more common due to emerging fluoroquinolone
			resistance. Disseminated gonococcal infection results in either of:</p>
		<ul>
			<li>
				<p>Septic arthritis</p>
			</li>
			<li>
				<p>Triad of dermatitis, tenosynovitis, and polyarthralgia</p>
			</li>
		</ul>
		<p>Disseminated gonococcal infection is:</p>
		<ul>
			<li>
				<p>Usually diagnosed in people &gt;40 years old</p>
			</li>
			<li>
				<p>4 times more common in women than in men</p>
			</li>
		</ul>
		<div class="table">
			<table>
				<caption><strong>Table 2.</strong> Microbiology of 505 cases of septic arthritis in large series reporting data 1999–2013.</caption>
				<thead>
					<tr>
						<th>
							Bacteria
						</th>
						<th>Number (%)</th>
					</tr>
				</thead>
				<tbody>
					<tr class="midrow">
						<td>
							Staphylococci
						</td>
						<td>282 (56)</td>
					</tr>
					<tr>
						<td>
							Methicillin-sensitive <em>Staphylococcus aureus</em> (MSSA)
						</td>
						<td>214 (42)</td>
					</tr>
					<tr>
						<td>
							Methicillin-resistant <em>S. aureus</em> (MRSA)
						</td>
						<td>51 (10)</td>
					</tr>
					<tr>
						<td>
							Coagulase-negative staphylococci
						</td>
						<td>17 (3)</td>
					</tr>
					<tr class="midrow">
						<td>
							Streptococci
						</td>
						<td>83 (16)</td>
					</tr>
					<tr>
						<td>
							Unspecified streptococcal species
						</td>
						<td>56 (11)</td>
					</tr>
					<tr>
						<td>
							<em>Viridans streptococci</em>
						</td>
						<td>7 (1)</td>
					</tr>
					<tr>
						<td>
							<em>Streptococcus pneumoniae</em>
						</td>
						<td>5(1)</td>
					</tr>
					<tr>
						<td>
							Other streptococcal species
						</td>
						<td>15 (3)</td>
					</tr>
					<tr class="midrow">
						<td>
							Gram-negative rods
						</td>
						<td>78 (15)</td>
					</tr>
					<tr>
						<td>
							<em>Pseudomonas aeruginosa</em>
						</td>
						<td>30 (6)</td>
					</tr>
					<tr>
						<td>
							<em>Escherichia coli</em>
						</td>
						<td>14 (3)</td>
					</tr>
					<tr>
						<td>
							<em>Proteus</em> species
						</td>
						<td>5 (1)</td>
					</tr>
					<tr>
						<td>
							<em>Klebsiella</em> species
						</td>
						<td>5 (1)</td>
					</tr>
					<tr>
						<td>
							Others
						</td>
						<td>21 (4)</td>
					</tr>
					<tr class="midrow">
						<td>
							Others
						</td>
						<td>62 (12)</td>
					</tr>
					<tr>
						<td>
							Polymicrobial
						</td>
						<td>25 (5)</td>
					</tr>
					<tr>
						<td>
							Anaerobes
						</td>
						<td>3 (0.6)</td>
					</tr>
					<tr>
						<td>
							<em>Mycobacterium tuberculosis</em>
						</td>
						<td>9 (1.8)</td>
					</tr>
					<tr>
						<td>
							<em>Neisseria gonorrhoeae</em> (gonococcus)
						</td>
						<td>6 (1.2)</td>
					</tr>
					<tr>
						<td>
							Miscellaneous
						</td>
						<td>19 (4)</td>
					</tr>
				</tbody>
			</table>
		</div>
		<h3 id="presentation-1">Presentation</h3>
		<p>Joint pain, swelling, warmth, and restricted movement occur in 80% of patients with septic arthritis.</p>
		<ul>
			<li>
				<p>Majority also present with fever</p>
			</li>
			<li>
				<p>Elderly may be afebrile</p>
			</li>
		</ul>
		<p>Non-gonococcal arthritis is monarthric in 80–90% of cases and affects the knee in 50%.</p>
		<p>The wrists, ankles, and hips are other commonly affected joints.</p>
		<p>Involvement of the small joints of the hands and feet and of the sternoclavicular or sternomanubrial joint
			suggests IV drug use.</p>
		<p>Polyarthric septic arthritis is more common in the setting of sepsis or connective tissue disease, such as
			rheumatoid arthritis or systemic <em>Lupus erythematosus</em>.</p>
		<hr />
		<figure>
			<img src="/figures/septic-arthritis.png" id="septicarthritispresentation"
				alt="Presentation of septic arthritis." />
			<figcaption aria-hidden="true"><strong>Figure 1.</strong> Presentation of septic arthritis.</figcaption>
		</figure>
		<hr />
		<div class="table">
			<table>
				<caption><strong>Table 3.</strong> Clinical and epidemiological features of septic arthritis.</caption>
				<thead>
					<tr>
						<th>Clinical or Epidemiological Feature</th>
						<th>Etiologic Agent</th>
					</tr>
				</thead>
				<tbody>
					<tr>
						<td>Rheumatoid arthritis</td>
						<td><em>Staphylococcus aureus</em></td>
					</tr>
					<tr>
						<td>Intravenous drug use</td>
						<td><em>S. aureus</em>, <em>Pseudomonas aeruginosa</em></td>
					</tr>
					<tr>
						<td>Diabetes, malignancy</td>
						<td><em>S. aureus</em>, <em>Streptococcus agalactiae</em></td>
					</tr>
					<tr>
						<td>Immunocompromised hosts</td>
						<td><em>S. aureus</em>, <em>Streptococci</em>, enteric Gram-negative bacilli, <em>Listeria
								monocytogenes</em></td>
					</tr>
					<tr>
						<td>Neonates, children younger than 4 years</td>
						<td><em>S. agalacticae</em>, Gram-negative bacilli, <em>Kingella kingae</em></td>
					</tr>
					<tr>
						<td>Young adults, menstruating female</td>
						<td><em>Neisseria gonorrhoeae</em></td>
					</tr>
					<tr>
						<td>Fibrocartilaginous joints (e.g., pubic symphysis)</td>
						<td><em>S. aureus</em>, <em>P. aeruginosa</em></td>
					</tr>
					<tr>
						<td>Postsurgical shoulder joint</td>
						<td><em>Cutibacterium acnes</em></td>
					</tr>
					<tr>
						<td>Cat or dog bite</td>
						<td><em>Pasteurella multocida</em>, <em>Capnocytophaga</em> spp., anaerobes</td>
					</tr>
					<tr>
						<td>Human bite</td>
						<td><em>Eikenella corrodens</em>, anaerobes, <em>Viridans streptococci</em></td>
					</tr>
					<tr>
						<td>Rat bite</td>
						<td><em>Streptobacillus moniliformis</em></td>
					</tr>
					<tr>
						<td>Postpartum women</td>
						<td><em>Mycoplasma hominis</em></td>
					</tr>
					<tr>
						<td>Ingestion of unpasteurized dairy products, residents or travelers from endemic areas</td>
						<td><em>Brucella</em> spp.</td>
					</tr>
					<tr>
						<td>Residents or travelers to Southeast Asia</td>
						<td><em>Burkholderia pseudomallei</em>, <em>Streptococcus suis</em></td>
					</tr>
					<tr>
						<td>After plant thorn injury</td>
						<td><em>Pantoea agglomerans</em>, <em>Nocardia</em> spp.</td>
					</tr>
				</tbody>
			</table>
		</div>
		<h3 id="diagnosis-8">Diagnosis</h3>
		<p><span class="h6">Labs:</span> CBC, CMP, ESR, CRP, synovial fluid cell counts, and GC/CT NAATs</p>
		<p><span class="h6">Imaging:</span> US vs CT vs. MRI (helpful to diagnosis periarthric osteomyelitis)</p>
		<p><span class="h6">Microbiology:</span> aerobic, anaerobic, fungal, and AFB synovial fluid cultures</p>
		<hr/>
		<div class="table">
			<table>
				<caption><strong>Table 4.</strong> Categories of synovial fluid based on clinical and laboratory findings. (<em><a href="https://www.uptodate.com/contents/image?imageKey=RHEUM%2F76506">UpToDate</a></em>)</caption>
				<tbody>
					<tr>
						<td>Measure</td>
						<td>Normal</td>
						<td>Noninflammatory</td>
						<td>Inflammatory</td>
						<td>Septic</td>
						<td>Hemorrhagic</td>
					</tr>
					<tr>
						<td>Volume, mL (knee)</td>
						<td>&lt;3.5</td>
						<td>Often &gt;3.5</td>
						<td>Often &gt;3.5</td>
						<td>Often &gt;3.5</td>
						<td>Usually &gt;3.5</td>
					</tr>
					<tr>
						<td>Clarity</td>
						<td>Transparent</td>
						<td>Transparent</td>
						<td>Translucent-opaque</td>
						<td>Opaque</td>
						<td>Bloody</td>
					</tr>
					<tr>
						<td>Color</td>
						<td>Clear</td>
						<td>Yellow</td>
						<td>Yellow</td>
						<td>Yellow</td>
						<td>Red</td>
					</tr>
					<tr>
						<td>Viscosity</td>
						<td>High</td>
						<td>High</td>
						<td>Low</td>
						<td>Variable</td>
						<td>Variable</td>
					</tr>
					<tr>
						<td>White blood cell, per microL</td>
						<td>&lt;200</td>
						<td>0 to 2000</td>
						<td>&gt;2000*</td>
						<td>&gt;20,000<sup>¶</sup></td>
						<td>Variable</td>
					</tr>
					<tr>
						<td>Polymorphonuclear leukocytes, percent</td>
						<td>&lt;25</td>
						<td>&lt;25</td>
						<td>≥50</td>
						<td>≥75</td>
						<td>50 to 75</td>
					</tr>
					<tr>
						<td>Culture</td>
						<td>Negative</td>
						<td>Negative</td>
						<td>Negative</td>
						<td>Often positive</td>
						<td>Negative</td>
					</tr>
				</tbody>
			</table>
			<p>* Inflammatory arthritis may include septic arthritis.<br>&para; Septic arthritis is typically associated with synovial fluid white blood cell counts &gt;20,000&nbsp;cells/microL, but lower counts may be observed, especially for arthritis due to disseminated gonococcal infection. With most bacterial organisms, particularly&nbsp;<em>Staphylococcus aureus</em>, the synovial fluid white blood cell count is typically &gt;50,000&nbsp;cells/microL (and often &gt;100,000 cells/microL).</p>
		</div>
		<hr/>
		<div class="table">
			<table>
				<caption><strong>Table 5.</strong> Characteristics of synovial fluid.</caption>
				<thead>
					<tr>
						<th>Synovial Fluid Characteristic</th>
						<th>Sensitivity</th>
						<th>Specificity</th>
						<th>Positive Likelihood Ratio (95% CI)</th>
						<th>Negative Likelihood Ratio (95% CI)</th>
					</tr>
				</thead>
				<tbody>
					<tr>
						<td>&gt;100,000 WBC/mm3</td>
						<td>29%</td>
						<td>99%</td>
						<td>28.0 (12.0–66.0)</td>
						<td>0.71 (0.64–0.79)</td>
					</tr>
					<tr>
						<td>&gt;50,000 WBC/mm3</td>
						<td>62%</td>
						<td>92%</td>
						<td>7.7 (5.7–11.0)</td>
						<td>0.42 (0.34–0.51)</td>
					</tr>
					<tr>
						<td>&gt;25.000 WBC/mm3</td>
						<td>77%</td>
						<td>73%</td>
						<td>2.9 (2.5–3.4)</td>
						<td>0.32 (0.23–0.43)</td>
					</tr>
					<tr>
						<td>PMN cells ≥90%</td>
						<td>73%</td>
						<td>79%</td>
						<td>3.4 (2.8–4.2)</td>
						<td>0.34 (0.25–0.47)</td>
					</tr>
				</tbody>
			</table>
		</div>
		<hr/>
		<h3 id="management-6">Management</h3>
		<hr/>
		<div class="table">
			<table>
			<caption><strong>Table 6.</strong> Management of septic arthritis.</caption>
				<thead>
					<tr>
						<th>Gram Stain</th>
						<th>Preferred Antibiotic</th>
						<th>Alternative Antibiotic</th>
					</tr>
				</thead>
				<tbody>
					<tr>
						<td>Gram-positive cocci</td>
						<td>Vancomycin 15–20 mg/kg (ABW) daily divided every 8–12 hrs</td>
						<td>Daptomycin 6–8 mg/kg daily or linezolid 600 mg IV or PO every 12 hrs</td>
					</tr>
					<tr>
						<td>Gram-negative cocci</td>
						<td>Ceftriaxone 1 g every 24 hrs</td>
						<td>Cefotaxime 1 g every 8 hrs</td>
					</tr>
					<tr>
						<td>Gram-negative bacilli</td>
						<td>Ceftazidime 2 g every 8 hrs or Cefepime 2 g every 8 hrs or Piperacillin-Tazobactam 4.5 g every 6 hrs
						</td>
						<td>Carbapenem (preferred alternative) or Fluoroquinolone or Aztreonam, 2 g every 8 hr</td>
					</tr>
					<tr>
						<td>Gram stain–negative</td>
						<td>Vancomycin plus Ceftazidime or Cefepime or Piperacillin-Tazobactam</td>
						<td>Daptomycin or linezolid plus Carbapenem (preferred alternative) or Fluoroquinolone or Aztreonam</td>
					</tr>
				</tbody>
			</table>
		</div>
	</div>
	<footer></footer>
</body>

</html>